Careers  |  Sign In  |  Register

New Single-Dose Remedy for MRSA Infection

A new drug has been developed and is proven to successfully treat MRSA in just a single dose, an article published in CBS News reports. Currently, patients with MRSA are prescribed antibiotics for 10 days, a solution which often includes spending time in the hospital. The new antibiotic, Oritavancin, was found to cure skin lesions more quickly in the first few days, and was equally as effective in curing patients after a one-week period. The study, published in the New England Journal of Medicine, separated two groups, each consisting of about 475 patients with MRSA, treating one with the traditional antibiotics for 7 to 10 days, and the other group with the new Oritavancin.

 Read the article published by CBS News.
Read the study published in the New England Journal of Medicine.